Literature DB >> 9597001

Induction of apoptosis in leukemia U937 cells by 5'-deoxy-5'-methylthioadenosine, a potent inhibitor of protein carboxylmethyltransferase.

S H Lee1, Y D Cho.   

Abstract

We found dramatic changes in leukemia U937 cells treated with 5'-deoxy-5'-methylthioadenosine (MTA), a potent inhibitor of protein carboxylmethyltransferase (protein methylase II). Initiation of cell death was observed by 1 day after MTA treatment, and it was induced in a dose- and time-dependent manner. However, cell viability measured by trypan blue exclusion was not consistent with the actual percentage of cell death. These results indirectly indicated that the type of cell death is apoptosis rather than necrosis. Nuclear fragmentation and DNA condensation of MTA-treated U937 cells were analyzed by both fluorescent and electron microscopy. MTA-treated cells first began to arrest in the M phase of the cell cycle, and they then exhibited a mitotic-like nuclear fragmentation process with partially membraneless chromatin. Furthermore, agarose gel electrophoresis of DNA extracted from cells treated with MTA showed DNA laddering with production of fragments of approximately 200 bp multiples. These studies indicated that cell death induced by MTA has the characteristics of apoptosis, although nuclear fragmentation is atypical. It seems likely that the process of apoptosis in U937 cells induced by MTA correlates with incomplete assembly of the nuclear envelope, since MTA itself could inhibit the carboxylmethylation of nuclear lamin B and delayed incorporation of lamin B into the nuclear envelope.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597001     DOI: 10.1006/excr.1998.4000

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Different apoptotic responses and patterns in adhering and floating neoplastic cell cultures: effects of microtubule antagonists.

Authors:  Luigi Sciola; Alessandra Spano; Gianni Monaco; Maria Grazia Bottone; Sergio Barni
Journal:  Histochem Cell Biol       Date:  2002-12-20       Impact factor: 4.304

2.  MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.

Authors:  Landon J Hansen; Ran Sun; Rui Yang; Simranjit X Singh; Lee H Chen; Christopher J Pirozzi; Casey J Moure; Carlee Hemphill; Austin B Carpenter; Patrick Healy; Ryan C Ruger; Chin-Pu J Chen; Paula K Greer; Fangping Zhao; Ivan Spasojevic; Carole Grenier; Zhiqing Huang; Susan K Murphy; Roger E McLendon; Henry S Friedman; Allan H Friedman; James E Herndon; John H Sampson; Stephen T Keir; Darell D Bigner; Hai Yan; Yiping He
Journal:  Cancer Res       Date:  2019-04-30       Impact factor: 12.701

3.  Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.

Authors:  Pedro Andreu-Pérez; Javier Hernandez-Losa; Teresa Moliné; Rosa Gil; Judit Grueso; Anna Pujol; Javier Cortés; Matias A Avila; Juan A Recio
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

4.  Protein L-isoaspartyl methyltransferase regulates p53 activity.

Authors:  Jae-Cheol Lee; Sung-Ung Kang; Yeji Jeon; Jong Woo Park; Jueng-Soo You; Shin-Won Ha; Narkhyun Bae; Gert Lubec; So Hee Kwon; Ju-Seog Lee; Eun-Jung Cho; Jeung-Whan Han
Journal:  Nat Commun       Date:  2012-06-26       Impact factor: 14.919

5.  Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.

Authors:  Jingjing Zhang; Yun Li; Hua Liu; Jiahui Zhang; Jie Wang; Jia Xia; Yu Zhang; Xiang Yu; Jinyan Ma; Masha Huang; Jiahui Wang; Liangzhe Wang; Qian Li; Rutao Cui; Wen Yang; Yingjie Xu; Weiwei Feng
Journal:  J Exp Clin Cancer Res       Date:  2022-01-15

6.  Methylthioadenosine (MTA) boosts cell-specific productivities of Chinese hamster ovary cultures: dosage effects on proliferation, cell cycle and gene expression.

Authors:  Natascha Verhagen; Julia Zieringer; Ralf Takors
Journal:  FEBS Open Bio       Date:  2020-11-11       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.